Why is Prism Medico falling/rising?

As of 08-Sep, Prism Medico & Pharmacy Ltd is experiencing a price increase, currently at 17.62, reflecting a change of 0.24 or 1.38% upward. The stock has shown strong performance in the short term, with a 1-week return of +6.08% and a 1-month return of +24.00%, significantly outperforming the Sensex, which has only gained +0.53% and +1.16% in the same periods, respectively. Today's price summary indicates that Prism Medico is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bullish trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 140.07% against the 5-day average. Positive financial results reported for June 25, including the highest quarterly PBDIT, PBT, and PAT, contribute to a favorable valuation despite a year-over-year profit decline of -3%. Broader market context shows that while Prism Medico has underperformed over the long term with a -32.88% return over the past year compared to the Sensex's -0.49%, its recent short-term gains indicate a potential recovery phase. The stock's liquidity is adequate for trading, and despite weak long-term fundamentals, including a negative CAGR growth in operating profits and a low return on equity, the recent positive quarterly results and increased trading activity may be driving current investor interest. Overall, the stock's recent upward movement can be attributed to short-term performance improvements and positive investor sentiment, contrasting with its longer-term challenges.